Ocata Therapeutics Inc fka OCAT

[chiefpalehorses]

"When I look at the financial performance of ACT, I wonder why it is worth anything at all.

ACT's business description sounds like it has a worthy goal: to use biotechnology to help people who are losing their eyesight. From its most recent quarterly statement: "The Company is engaged in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The Company is conducting clinical trials for treating dry age-related macular degeneration and Stargardt's macular degeneration."

Sadly, ACT's accomplishments in science are not matched by its ability to account for its operations according to the rules. Last March, ACT announced it had made errors in its financial statements going back five years. "

*ACTC* As popular as poison.